Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,144
archived clinical trials in
Ocular

PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated:  12/31/1969
Florida Retina Consultants
mi
from
Lakeland, FL
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated: 12/31/1969
Florida Retina Consultants
mi
from
Lakeland, FL
Click here to add this to my saved trials
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated:  12/31/1969
Southeast Eye Institute, P.A. dba Eye Associates of Pinellas
mi
from
Pinellas Park, FL
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated: 12/31/1969
Southeast Eye Institute, P.A. dba Eye Associates of Pinellas
mi
from
Pinellas Park, FL
Click here to add this to my saved trials
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated:  12/31/1969
Sarasota Retina Institute
mi
from
Sarasota, FL
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated: 12/31/1969
Sarasota Retina Institute
mi
from
Sarasota, FL
Click here to add this to my saved trials
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated:  12/31/1969
Southeast Retina Center, P.C.
mi
from
Augusta, GA
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated: 12/31/1969
Southeast Retina Center, P.C.
mi
from
Augusta, GA
Click here to add this to my saved trials
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated:  12/31/1969
Thomas Eye Group
mi
from
Sandy Springs, GA
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated: 12/31/1969
Thomas Eye Group
mi
from
Sandy Springs, GA
Click here to add this to my saved trials
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated:  12/31/1969
John-Kenyon American Eye Institute
mi
from
New Albany, IN
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated: 12/31/1969
John-Kenyon American Eye Institute
mi
from
New Albany, IN
Click here to add this to my saved trials
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated:  12/31/1969
Wolfe Eye Clinic
mi
from
West Des Moines, IA
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated: 12/31/1969
Wolfe Eye Clinic
mi
from
West Des Moines, IA
Click here to add this to my saved trials
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated:  12/31/1969
Mid-America Retina Consultants, P.A.
mi
from
Overland Park, KA
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated: 12/31/1969
Mid-America Retina Consultants, P.A.
mi
from
Overland Park, KA
Click here to add this to my saved trials
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated:  12/31/1969
Retina and Vitreous Associates of Kentucky
mi
from
Lexington, KY
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated: 12/31/1969
Retina and Vitreous Associates of Kentucky
mi
from
Lexington, KY
Click here to add this to my saved trials
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated:  12/31/1969
Elman Retina Group, PA
mi
from
Baltimore, MD
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated: 12/31/1969
Elman Retina Group, PA
mi
from
Baltimore, MD
Click here to add this to my saved trials
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated:  12/31/1969
Valley Eye Physicians & Surgeons
mi
from
Ayer, MA
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated: 12/31/1969
Valley Eye Physicians & Surgeons
mi
from
Ayer, MA
Click here to add this to my saved trials
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated:  12/31/1969
Vitreo-Retinal Associates
mi
from
Grand Rapids, MI
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated: 12/31/1969
Vitreo-Retinal Associates
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated:  12/31/1969
The Retina Institute
mi
from
Saint Louis, MO
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated: 12/31/1969
The Retina Institute
mi
from
Saint Louis, MO
Click here to add this to my saved trials
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated:  12/31/1969
Charlotte Eye Ear Nose and Throat Assoc, PA
mi
from
Charlotte, NC
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated: 12/31/1969
Charlotte Eye Ear Nose and Throat Assoc, PA
mi
from
Charlotte, NC
Click here to add this to my saved trials
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated:  12/31/1969
Retina Vitreous Center
mi
from
Edmond, OK
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated: 12/31/1969
Retina Vitreous Center
mi
from
Edmond, OK
Click here to add this to my saved trials
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated:  12/31/1969
Southeastern Retina Associates, P.C.
mi
from
Knoxville, TN
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated: 12/31/1969
Southeastern Retina Associates, P.C.
mi
from
Knoxville, TN
Click here to add this to my saved trials
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated:  12/31/1969
Retina Research Center
mi
from
Austin, TX
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated: 12/31/1969
Retina Research Center
mi
from
Austin, TX
Click here to add this to my saved trials
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated:  12/31/1969
Retina Center of Texas
mi
from
Grapevine, TX
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated: 12/31/1969
Retina Center of Texas
mi
from
Grapevine, TX
Click here to add this to my saved trials
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated:  12/31/1969
Retina Consultants of Houston
mi
from
Houston, TX
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated: 12/31/1969
Retina Consultants of Houston
mi
from
Houston, TX
Click here to add this to my saved trials
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated:  12/31/1969
Retinal Consultants of San Antonio
mi
from
San Antonio, TX
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated: 12/31/1969
Retinal Consultants of San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated:  12/31/1969
Arizona Retina and Vitreous Consultants
mi
from
Phoenix, AZ
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated: 12/31/1969
Arizona Retina and Vitreous Consultants
mi
from
Phoenix, AZ
Click here to add this to my saved trials
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated:  12/31/1969
Macula and Retina Institute
mi
from
Glendale, CA
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated: 12/31/1969
Macula and Retina Institute
mi
from
Glendale, CA
Click here to add this to my saved trials
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated:  12/31/1969
South Coast Retina Center
mi
from
Long Beach, CA
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated: 12/31/1969
South Coast Retina Center
mi
from
Long Beach, CA
Click here to add this to my saved trials
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated:  12/31/1969
Retina Macula Specialists of Miami
mi
from
Miami, FL
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated: 12/31/1969
Retina Macula Specialists of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated:  12/31/1969
Florida Retina Institute
mi
from
Orlando, FL
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated: 12/31/1969
Florida Retina Institute
mi
from
Orlando, FL
Click here to add this to my saved trials
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated:  12/31/1969
Illinois Retina Associates, SC
mi
from
Oak Park, IL
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated: 12/31/1969
Illinois Retina Associates, SC
mi
from
Oak Park, IL
Click here to add this to my saved trials
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated:  12/31/1969
Retina Associates, PA
mi
from
Shawnee Mission, KA
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated: 12/31/1969
Retina Associates, PA
mi
from
Shawnee Mission, KA
Click here to add this to my saved trials
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated:  12/31/1969
Ophthalmic Consultants of Boston
mi
from
Boston, MA
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated: 12/31/1969
Ophthalmic Consultants of Boston
mi
from
Boston, MA
Click here to add this to my saved trials
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated:  12/31/1969
Retina Associates of Western New York
mi
from
Rochester, NY
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated: 12/31/1969
Retina Associates of Western New York
mi
from
Rochester, NY
Click here to add this to my saved trials
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated:  12/31/1969
Retina-Vitreous Surgeons of Central New York, PC
mi
from
Syracuse, NY
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated: 12/31/1969
Retina-Vitreous Surgeons of Central New York, PC
mi
from
Syracuse, NY
Click here to add this to my saved trials
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated:  12/31/1969
Western Carolina Clinical Research, LLC
mi
from
Asheville, NC
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated: 12/31/1969
Western Carolina Clinical Research, LLC
mi
from
Asheville, NC
Click here to add this to my saved trials
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated:  12/31/1969
Retina Vitreous Consultants
mi
from
Monroeville, PA
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated: 12/31/1969
Retina Vitreous Consultants
mi
from
Monroeville, PA
Click here to add this to my saved trials
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated:  12/31/1969
Southeastern Retina Associates
mi
from
Chattanooga, TN
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated: 12/31/1969
Southeastern Retina Associates
mi
from
Chattanooga, TN
Click here to add this to my saved trials
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated:  12/31/1969
Emory Eye Center
mi
from
Atlanta, GA
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated: 12/31/1969
Emory Eye Center
mi
from
Atlanta, GA
Click here to add this to my saved trials
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated:  12/31/1969
Northwestern Medical Faculty Foundation
mi
from
Chicago, IL
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated: 12/31/1969
Northwestern Medical Faculty Foundation
mi
from
Chicago, IL
Click here to add this to my saved trials
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated:  12/31/1969
Eye Associates of Northeast Louisiana dba Haik Humble Eye Center
mi
from
West Monroe, LA
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated: 12/31/1969
Eye Associates of Northeast Louisiana dba Haik Humble Eye Center
mi
from
West Monroe, LA
Click here to add this to my saved trials
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated:  12/31/1969
Kellogg Eye Center at University of Michigan
mi
from
Ann Arbor, MI
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated: 12/31/1969
Kellogg Eye Center at University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated:  12/31/1969
Henry Ford Health System, Dept of Ophthalmology and Eye Care Services
mi
from
Detroit, MI
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated: 12/31/1969
Henry Ford Health System, Dept of Ophthalmology and Eye Care Services
mi
from
Detroit, MI
Click here to add this to my saved trials
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated:  12/31/1969
The Retina Center
mi
from
Minneapolis, MN
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated: 12/31/1969
The Retina Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated:  12/31/1969
Eye Associates of New Mexico
mi
from
Albuquerque, NM
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated: 12/31/1969
Eye Associates of New Mexico
mi
from
Albuquerque, NM
Click here to add this to my saved trials
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated:  12/31/1969
MaculaCare
mi
from
New York, NY
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated: 12/31/1969
MaculaCare
mi
from
New York, NY
Click here to add this to my saved trials
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated:  12/31/1969
Kittner Eye Center
mi
from
Chapel Hill, NC
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated: 12/31/1969
Kittner Eye Center
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated:  12/31/1969
Dean A. McGee Eye Institute
mi
from
Oklahoma City, OK
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated: 12/31/1969
Dean A. McGee Eye Institute
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated:  12/31/1969
Robert E. Torti, MD, PA dba Retina Specialists
mi
from
DeSoto, TX
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated: 12/31/1969
Robert E. Torti, MD, PA dba Retina Specialists
mi
from
DeSoto, TX
Click here to add this to my saved trials
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated:  12/31/1969
Baylor Eye Physicians and Surgeons
mi
from
Houston, TX
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated: 12/31/1969
Baylor Eye Physicians and Surgeons
mi
from
Houston, TX
Click here to add this to my saved trials
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated:  12/31/1969
Valley Retina Institute, P.A.
mi
from
McAllen, TX
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated: 12/31/1969
Valley Retina Institute, P.A.
mi
from
McAllen, TX
Click here to add this to my saved trials
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated:  12/31/1969
Medical Center Ophthalmology Associates
mi
from
San Antonio, TX
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated: 12/31/1969
Medical Center Ophthalmology Associates
mi
from
San Antonio, TX
Click here to add this to my saved trials
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated:  12/31/1969
Retina Institute of Virginia
mi
from
Richmond, VA
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated: 12/31/1969
Retina Institute of Virginia
mi
from
Richmond, VA
Click here to add this to my saved trials
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated:  12/31/1969
Loma Linda University Health Care, Department of Ophthalmology
mi
from
Loma Linda, CA
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated: 12/31/1969
Loma Linda University Health Care, Department of Ophthalmology
mi
from
Loma Linda, CA
Click here to add this to my saved trials
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated:  12/31/1969
University of Florida College of Med., Department of Ophthalmology, Jacksonville Health Science Cent
mi
from
Jacksonville, FL
PROMINENT-Eye Ancillary Study (Protocol AD)
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Status: Enrolling
Updated: 12/31/1969
University of Florida College of Med., Department of Ophthalmology, Jacksonville Health Science Cent
mi
from
Jacksonville, FL
Click here to add this to my saved trials